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THE demonstration that isoniazid (INH) is carcinogenic for the lungs of
mice (Juhasz, Balo and Kendrey, 1957) raised a new type of cancer problem.
Most known carcinogens are avoidable as human hazards and many are subject
to restrictive legislation. However, INH is a valuable life-saving drug in the
control oftuberculosis, and the assessment of it as a potential carcinogenic hazard
for man is therefore a matter of unusual concern.
Moreover, it must be noted that the induction of pulmonary alveolar adenoma
or adenocarcinoma in mice by a variety of chemically dissimilar carcinogens
(e.g. urethane and 4-nitro-quinoline-N-oxide) is most striking in those strains,
such as A and BALB/c, which have a high spontaneous incidence ofsuch tumours.
Tumours of similar histogenesis can be induced experimentally in rats but they
very rarely occur spontaneously. In terms of initiators and promoters, mice
of different strains behave as though they have variable amounts of some inborn
initiator which determines the response of their alveolar cells to a variety of
carcinogenic promoters. Apart from known genetic factors no " initiator " as
postulated has been identified.
It seemed desirable, therefore, to assay INH on animals other than mice,
under comparable conditions of exposure, and at non-toxic dosage, for the major
part of their lives.
MATERIAL AND METHODS
All rodents were fed on Diet No. 41 pellets.
Pilot experiments showed that with our strains of C3Hf mice and BALB/c
mice a single subcutaneous injection of 2 mg. or a daily oral intake of 2 mg. INH
per adult mouse of about 20 g. was toxic for about a third of the animals, but
was tolerated when given by gastric intubation not more frequently than twice a
week, or daily in drinking water probably because in the latter case the drug was
taken gradually over 24 hours.
Subcutaneous injection
Mice- Thirty male and 10 female C3Hf aged between 5-17 weeks and 23 male
and 16 female BALB/c mice aged between 7-36 weeks were injected subcutane-
ously with 0-2 ml. of INH solution equivalent to 2 mg. per injection.
At first injections were given three times a week, but owing to heavy mortality
and evidence of peripheral neuritis in the survivors, the frequency of injection
was reduced. Thus those which died early in the experiment received relatively
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higher total dosage. The total dose va-ried somewhat between mice, because
those which looked sick were not injected until they had recovered. Over a
period of 8 months 56 injections were given.
Results.-No pulmonary tumours were seen in mice which died at less than
40 weeks of age. Of C3Hf mice that survived beyond this age, of 17 males only
1, which died aged 36 weeks, had a deep-seated papillary adenoma; no pulmonary
tumours occurred in 6 female survivors (Table I).
TABLE J.-INH Subcutaneous Injections-C3Hf Mice
Age in weeks Period INH
~~~ ~ of in- Total Lung
at at jection dose Autopsy and histological
No. start death (weeks) (mg.) 1 2 3 4 diagnosis
Males
1144/9 .8 8 I day 2. .Acute toxaemia.
1144/10. 8 8 I iday 2 5
1166/57 .8 8 .I day 2. .Haemorrhagic enteritis.
1143/5 .8 9 I 4. .Toxaemia.
1143/6. 8 9 I 1 4
1143/4 .8 10 2 8. .Lung congasted. Desquamation
of brcnchial epithelium.
1144/11 .8 10 2 . 8.Toxaemia; no gross lesions.
1144/13. 8 10 2 8 I 5
1143/45. 8 14 . 6 16 9 9 9~ 9
1146/17. 8 14. 6. 24 . . ?TumourR.A.lobe.*
1146/20. 8 14. 6. 20.No gross lung lesions. Urethra
blocked by vesical calculus.
1146/19 8 15 7 24.No gross lesions.
1166/60. 8 17. 9. 30.Lungs congested. Peribronchial
lymphangitis.
1165/55 .8 17 9 .30.Lungs congested.
1165/52 .8 29 .21 .60.Lungs congested.
1160/27 .21 30 9 .22.No grosslesions.
1146/15 .8 35 .27 .80.Lungs and kidneys acutely con-
gested.
1182/71 .8 36 .25 .88 . . Congested lung. Papillary aden-
oma of hilum; traumatic
obstruction ofpenis; retention
of urine.
1166/63 .8 46 .30 .96.No gross lesions.
1160/30. 21 52. 31. 64.No gross lesions in lungs. Neck
broken by cage.
1146/16 .8 63 .36 .116.Acutecongestionoflung.
1160/29 .21 66 K .35 .102.No gross lesions in lungs.
1182/68 .8 68 K .25 .88.Lungs congested.
1182/70. 8 68K. 25 .88
1182/72. 8 68K 25 -88 .. .
1165/51 .8 69 K .30 .96.Congested lungs and kidneys.
1166/59 .8 69 K .30 .96.No gross lesions in lungs.
1143/7 .8 73K .36 .116.?TumourR.M.lobe.*Subpleural
oedema and lymphangitis.
1143/2 8 74 36 116.No gross lesions.
1182/69 .8 92 .25 .88.Lungs congested.
Females
1181/64 .8 8 I day 2.Acute toxaemia.
1181/65. 8 8 I iday 2
1181/66. 8 8 I iday 2
1181/67 .8 12 2 . 4.Patchy congestion.
1183/77 .8 16 6 .11.No gross lesions in lung.
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TABLE I. (contd)
Age in weeks Period INH
of in- Total Lung
at at jection dose A Autopsy and histological
No. start death (weeks) (mg.) 1 2 3 4 diagnosis
1183/74 8 28 . 17 . 25 .Lung: slight alveolar exudate
and lymphocytosis.
1181/63 . 8 28 . 17 . 25 .Lung congested; fibrinous exu-
date in alveoli.
1183/73 . 8 29 . 21 . 37 .White spots R.U. and R.L.
Lung congested.
1183/75 . 8 68 K . 26 . 44 .No gross lesions.
The following abbreviations have been used throughout the tables:
K = Killed.
* = Not histologically confirmed.
Lung: Column 1 = Papillary adenoma of subpleural origin.
2 = Papillary adenoma of other sites.
3 = Alveolar hyperplasia of subpleural origin.
4 = Alveolar hyperplasia of other sites.
Lobes of Lung: R.U. = Right upper.
R.M. = Right middle.
R.L. = Right lower.
R.A. = Right azygos.
L. = Left.
Among male BALB/c mice which survived for more than 40 weeks, 8 out of
19 had no pulmonary tumours. In the remaining 11 there were 8 with subpleural
papillary adenomata, 6 with papillary adenomata at other sites, 1 with hyperplasia
at subpleural and at other sites.
Among 11 females, over 40 weeks old, 3 had no pulmonary tumours. Among
8 with lung tumours, 6 had subpleural papillary adenomata at other sites and 3
had alveolar hyperplasia at other sites and 1 at subpleural and at other sites
(Table II).
Gastric intubation
Twenty-four male and 17 female BALB/c mice were given INH by gastric
intubation three times a week, or less frequently if toxic effects appeared, for 40
to 45 weeks. A daily dose of2 mg. caused some early deaths due to toxicity ofthe
drug. Sixteen males and 11 females survived for more than 40 weeks, but all
died or were killed by 65 weeks. The survival, duration of exposure and total
dose of INH and site and type of tumour are shown in Table III.
Results.-One subpleural and one deep-seated papillary adenoma in a male
and one subpleural tumour, not confirmed histologically, and one subpleural
papillary adenoma in a female were found; all others were free of pulmonary
tumours, but most of them had chronic respiratory lesions, septic bronchitis,
bronchopneumonia, or bronchiectasis.
It was found impossible to distinguish infected tumours from peripheral
bronchiectatic abscesses on naked eye examination and only microscopic examina-
tion ofserial sections revealed the true character ofdifferent lesions (Fig. 1 and 2).
It was felt that daily administration without instrumentation of any kind
was preferable because it resembled the method of administration to human
patients. Metabolic studies (Chalmers, 1965) showed that the drug was absorbed,
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TABLE JI.-INH Subcutaneous Injections-BALBIc Mice
Age in weeks Period INH
(A _ of in- Total Lung
at at jection dose Autopsy and histological
No. start death (weeks) (mg.) 1 2 3 4 diagnosis
Males
1150/22. 5 9 4 . 20 .. ? Toxaemia; no abnormality
found.
1163/51 7 9 2 12 .. Lung congested.
1184/86 .15 18 . 3 . 18 .. Bronchopneumonia.
1135/34 I 11 25 14 56 .. Pneumonia.
1150/39 5 40 35 . 96 . 2 mm. tumour R.L. at base.
Papillary adenoma.
1135/42 .6 43 K .35 .78 . . No abnormality found. Lymph.
atic engorgement.
1135/35 .11 48 K 35 . 78 .. No abnormality found. Lymph.
atic engorgement.
1135/33 .11 48 K 35 . 78 .. No abnormality found. Lymph-
atic engorgement.
1163/48. 7 67 K. 35 88 . . ±2 mm. tumour in R.L. Multi-
focal papillary adenoma invad-
ing bronchioldes.
1163/49. 7 67 K. 35 88 .. + . . 6 mm. tumour in base. Multi-
focal papillary adenoma sur-
rounded by normal lung.
1163/50 7 67 K 35 88 .+ + . . Multiple tumours R.L. and L.
lobes.
1150/24 5 67 K - 35 .116 + . Tumours R.A. and L. lobes at
base.
1150/26 5 67 K 35 .116 .+ + . . Multiple tumours at R. and L.
bases. Multifocal papillary
adenoma.
1184/83 .15 72 K 35 84. . . No abnormality found.
1184/84 -15 72 K 35 84 + . Multiple subpleural tumours.
1184/82 .15 72 K 35 84 + + A- Multiple tumnours. Multifocal
papillary adenoma and carci-
noma; also diffuse alveolar
hyperplasia.
1136/36 .10 73K. 35 .112 ± . TumourL. lobe.
1136/37- 10 73 K. 35 . 112 . + + . . Multiple tumours. Multifocal
papillary adenoma and carci-
noma.
1136/38 .10 73 K 35 .112. . . No abnormality found.
1185/78. 16 73K. 35 84 1
1185/80. 16 73K. 35 .84
1185/81. 16 73K. 35 84 .
1185/82 .16 72K 35 84 * +~ . . Tumour R.L. lobe.
Females
1137/3 7 11 4 20 . . . Lung congested.
1142/1 10 11 I 6
1142/2 10 11 I 6
1142/3 10 11 I 6
1142/4 10 12 2 12
1186/79. 11 55 K. 34 . 84 . + . Tumour R.L. lobe. Papillary
adenoma.
1137/44 . 7 67 48 .112. . . Lymphatic engorgement.
1197/73 .36 67K. 9 .56 .+ +. .2tumoursL.
1137/4 . 6 70 K. 38 112 . + + + +. Small tumours R. Hydrosal-
pynx.
1137/2 6 70 K 38 .112. . . No abnormality found.
1164/51 8 71 K . 37 84 . + .Small tumours, all lobes.
1164/49 8 71 K . 37 . 84 . .No abnormality found.
1179/70 .36 86 K 9 . 56 . + .Multifocal papillary adenoma;
leukaemia; ascites.
1179/76 .36 87 K .9 .56. .Mammary adenocarcinoma..±3;
metastasis in lung.
1179/72. 36 92 K 9 . 56 . + +Many tumours in lung. Multi-
focal papillary adenoma. Mam-
mary adenocarcinoma R.2.
1179/74 .36 92 K 9 56 . .Lymphomatosis.TOXICITY OF ISONIAZID 311
TABLE JJJ.-INH Feeding by Gastric Intubation-BALB/c Mice
Age in weeks INH
~~~~Dura- Total Lung
at at tion dose Autopsy and histological
No. start death (weeks) (mg.) 1 2 3 4 diagnosis
Males
1141/10 .10 43 .33 .138.Generallymphomatosis,visceral,
skeletal, liver, spleen.
2010/3 .12 47 .35 .140. .Septic bronchitis.
1162/81 .10 47 .37 .140. .Bronchopneumonia.
1162/79 -10 50K -40 -143- -Multifocal lesions R.A. and R.L
Bronchopneumonia.
1162/80 .9 52 .43 .143. .Septic bronchitis and lymphan-
gitis.
1183/5 .7 53 .42 .145 .BronchiectasisR.M.,R.L.,R.A.;
'?tumour R.U.; broncho-
pneumonia. Papillary aden-
oma.
1162/78 .7 53 K .44 .148. .Bronchopneumonia. Adenosis
of bronchi.
1138/1 .8 59 K .44 .148. .Bronchiectasis.
1138/2. 8 59K. 42. 148 . +Tumour iR.M. Adenoma.
1138/3 .8 59K. 44 .148 . . TumourR.L.base.
1138/6 .8 59 K .44 .148. .Bronchopneumonia. Thymoma.
1138/4 .8 59K. 44 .148 1
1141/7 .8 62 K .42 .146. .Bronchitis R. lobes.
1141/9 .8 62 K .42 .146. .Bronchiectasis.
2010/1 .12 65K. 40 .140 99
2010/2 .12 65K. 40 .140
Females
1139/9 .9 10 I 4 .. Early penumonic consolidation.
1161/42 .10 14 4 .16 .. Infarctsinliver.
1139/5 .8 17 K 9 .36 .. Nothi'ng abnormal found.
1149/22. 7 19 . 12 36.,,1 1 ~ ly9
1140/10. 10 44. 34. 138 .+Tumour R.A. and L. Small
compact papillary adenoma.
1161/41 .10 53 K .40 .143.Septic bronchitis and bronchi-
ectasis.
1161/45 .10 53 .40 .143.Septic bronchitis and bronchi-
ectasis.
1149/26. 7 55. 43. 145.Bronchitis and bronchopneu.
monia.
1140/8 .8 56 .42 .145.Peribronchial lymphangitis.
1161/47 .8 58 K .40 .143.Unresolved bronchopneumonia.
1161/46. 9 59 K. 40. 143.Bronchiectasis and broncho-
pneumonia.
1149/24. 9 60 K. 40. 145.Bronchiectasis and broncho-
pneumonia.
1139/6 .9 60 K .40 .145.Bronchopneumonia.
1139/7 .9 60K. 40 .145
1
1140113 .7 61 K .44 .148.Nothing abnormal found.
and metabolites were recovered from the urine. The above methods of assay
were abandoned, therefore, in favour ofdaily administration ofthe drug in drinking
water.
INH in drinking water
Thirty-six male and 14 female C3Hf and 15 male and 20 female BALB/c
mice, aged 6 to 14 weeks, were given 01I% aqueous INH solution in drinking
bottles and consumed on average between 2 and 3 ml. (2 to 3 mg. INH) per mouseANDREE PEACOCK AND P. R. PEACOCK
per day throughout their lives. All those that died naturally were examined as
soon as possible after death, and even in those which showed autolytic changes
it was generally possible to recognise pulmonary tumours when present. Sick
mice at any age were killed, and all survivors were killed when 2 years of age,
and immediately autopsied.
Re,sults.-At approximately 2X5 mg. of INH per average 20 g. adult mouse
the dosage was considered to be the highest tolerable and 8 C3Hf and 1 BALB/c
mice died within 24 hours of the experiment. Thus the effective population of
50 C3Hf and 35 BALB/c was selected for tolerance.
No pulmonary tumours occurred in mice which died below 30 weeks of age
and only those which survived beyond this period are considered in assessing
the carcinogenic response (Tables IV and VI).
EXPLANATION OF PLATES
FIG. 1.-BALB/c Female 1271/34 INH in drinking water (Table VI). Age 98 weeks. Killed
in good condition. Total dose of INH = 628 mg. Multiple tumours in lungs. Van
Gieson and elastin. x 120. Section shows alveolar hyperplasia (upper right) and peri-
vascular and parabronchial lymphatic engorgement (upper left). In the normal lung there
is little evidence ofcompression by the lesion. The arrangement ofelastin (thin black lines)
is normal throughout the hyperplastic lesion.
FIG. 2.-Same mouse as above. Another field from the same section shows desquamative
alveolar hyperplasia (upper left) merging into papillary adenoma (centre). The underlying
normal lung is slightly compressed by the tumour. Elastin is deficient in the papilloma and
the alveolar pattern is distorted.
FIG. 3. Wistar Rat Female 57/35 INH in drinking water (Table VIII). Age 113 weeks.
Killed in good condition. Total dose ofINH = 13-0 g. Lungs healthy apart from a 3 mm.
subpleural lesion on the posterior aspect of the left lobe at the level of the 8th rib. Picro-
Mallory and elastin. x 60. Section shows part of a wedge shaped subpleural area of mixed
alveolar hyperplasia and early papillary adenoma, with a small focus of distended alveoli
containing unidentified non-birefringent elongated foreign bodies partly phagocytosed
(circled). Note abrupt transition from normal to hyperplastic epithelium and preservation
of normal alveolar pattern. Slight thickening of the pleura is visible (top right).
FIG. 4. Same slide as above showing pleura as a dense black diagonal line with hyperplastic
alveolarepithelium (left) showingpartly defective elastic basement membrane as a thin wavy
line (A); to the right of the field dilated pleural lymphatics (L) are invaded by more neo-
plastic epithelium which is devoid of elastin (B). x 340.
FIG. 5. Wistar Rat Male 75/4 INH in drinking water (Table IX). Age 61 weeks. Killed for
rectal prolapse. Total dose of INH = 3- 63 g. Unresolved bronchopneumonia and peri-
bronchial adenosis was present but no neoplastic lesions were found in the lungs. There was
a fleshy ulcerated tumour about 1 cm. in diameter surrounding the anal prolapse. H. and E.
x 110. Section shows a representative field. A keratinised squamous papilloma shows
mitotic activity and a tendency to invade the narrow strand of connective tissue stroma.
FIG. 6. Wistar Rat Female 76/7 INH in drinking water and food (Table IX). Age 78 weeks.
Killed for rectal prolapse and anal papilloma. Total dose of INH = 6-23 g. No gross
internal lesions found. Van Gieson and elastin x 55. Section shows keratinised papilloma
of anal skin (left) and complete squamous metaplasia of rectal glands which are packed
with keratin (right). The submucous lymphatics are greatly distended.
FIG. 7.- Wistar Rat Female 76/8 INH in drinking water and food (Table IX). Age 78 weeks.
Killed for large prolapsed tumour of anal region. Total dose of INH = 6-23 g. No gross
internal lesions found. Van Gieson and elastin x 55. Section through prolapsed tumour
shows some functional glands in which mucus appears black, and sqaamous metaplasia and
neoplasia in adjacent glands (the carcinoma is not illustrated).
FIG. 8. Wistar Rat Female 76/6 INH in drinking water and food (Table IX). Age 108 weeks.
Killed for anal polyp and prolapse. A diaphragrnatic hernia containing part of the central
lobe of the liver was the only internal lesion found. H. and E. x 110. Section shows
part of an oedematous polyp (top) and metaplastic and hyperplastic glands (below) with a
few normal rectal glands.
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TABLEIJV.-INH in Drinking Water-C3Hf Mice
Age in weeks INH
~~~ ~ Dura- Total Lung
at at tion dose A---'------ Autopsy and histological
No. start death (weeks) (mg.) 1 2 3 4 diagnosis
Males
1230/33 .12 12 .1 day 2 .. Toxaemia.
1230/34 .11 12 .6 days 12 .. Intense congestion all organs.
1239/49 7 12 . 5 70 .. Killed in extremis.
1226/20 .14 15 .3 days 6 .. Early pneumonia.
1226/18. 14 16 .10 ,, 20 99
1238/45. 14 49 35 130 .. Nil in lungs; haemorrhagic
gastroenteritis.
1240/52. 7 72 . 65 500 .. ? Tumour L. lung. Epithelial
desquamation only.
1222/1 .17 74 K 57 .408 .. No abnormality found.
1222/3 .17 74K. 57 .408 , 9 9
12292/5 .17 74 K 57 .408 . +Small 1 mmn. tumour central.
Papillary adenoma.
1224/13. 14 86 72 480 . + . Tumour R.L. lobe. Alveolar
hyperplasia.
1233/39. 6 94 . 88 . 480 + +Whole L. lobe replaced by
tumour. Diffuse multifocal
papillary adenoma.
1223/6 . 10 100 K. 90 . 570 .. + . Small tumour R.A. lobe. Cen-
tral adenocarcinoma invading
bronchi and veins.
1238/44 .14 101 . 87 .620 . + + +.Lungs congested with pale area
L. Congestion, alveolar hyper.
plasia, papillary adenoma.
1239/47. 8 104 K. 96 . 660 .+ + + + Tumour L. lobe. Multifocal
papillary adenoma and alveolar
hyperplasia.
1239/48. 8 104 K. 96 660 .± . + .. Multiple tumours. Papillary
adenoma and alveolar hyper.
plasia.
1239/50. 8 104 K. 96 660 .. + . Tumour R.L. lobe. Papillary
adenoma.
1240/51. 9 105 K. 96 660 .. + . Tumour L. base. Papillary
adenoma.
1240/52. 9 105 K. 96 660 .. + . Multiple tumours L. Multifocal
papillary adenoma.
1240/53. 9 105 K. 96 660 .. + ..+. Tumour L. lobe. Central papil-
lary adenoma and alveolar
hyperplasia.
1273/60. 14 105 K. 96 660 . ++. 3 Tumours L. lobe. Alveolar
hyperplasia.
1273/61. 14 105 K. 96 660 .. + . ? Tumour L. lobe. Central
papillary adenoma.
1224/12. 14 106 K. 92 . 650 .. + . Tumour R.U. lobe. Trabecular
hepatoma.
1238/43. 14 106 K. 92 . 650 . +Large tumour R. hip. Spindle
cell sarcoma; lung metastasis,
also papillary adenoma.
1224/11. 14 107 92 650 .. Lung congested. Trabecular
hepatoma.
1238/46. 14 110K. 95 660 . ±Tumours L. lobe. Papillary
adenoma and carcinoma.
1223/7 10 111 K. 100 . 680 . + . Tumour L. lobe. Alveolar
hyperplasia; lymphomatosis.
1233/40. 6 112 K. 105 . 690 .+ + + + Tumours R. and L. Multifocal
papillary adenoma, alveolar
hyperplasia.
1233/41. 6 112 K. 105 690 .. ? Tumour L. lobe. Lymphatic
engorgement.
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TABLE IV. (contd)
Age in weeks
at at
No. start death
1233/42 . 6 112 K
Dura-
tion
(weeks)
105
1228/25 . 8 113 K . 105
1228/26 . 8 113 K . 105
1223/8
1223/9
10
10
115 K.
115 K.
105
105
1224/10 . 14 120 K . 105
1226/21 . 11 120 K . 105
INH
Total Lung
dose __ _ Autopsy and histological
(mg.) 1 2 3 4 diagnosis
690 . ± + + + . ? Tumour R.A. and L. Diffuse
multifocal alveolar hyperplasia;
papillary adenoma and carci-
noma.
690...+ + Dextrocardia. Tumour L. hilum
and R. lobe; diffuse alveolar
hyperplasia.
690 + + + + . Multiple tumours in lung. Multi-
focal papillary adenoma, alveo-
lar hyperplasia, trabecular
hepatoma.
690 . + ±...Multiple tumours. Papillary
adenoma and carcinoma.
690 +....Congested lung. Papillary ade-
noma; metastatic malignant
hepatoma.
690 . + + .. Multiple tumours. Papillary
adenoma, alveolar hyperplasia;
multiple hepatoma.
690...+ .. Tumours R.U. and R.M. lobes.
Alveolar hyperplasia.
Females
1232/36
1232/37
1241/55
1229/31
1229/32
1227/19
1225/14
1225/15
1232/38
1272/35
1231/35
8
8
8
8
8
8
8
7
26
11
12
7
7
7
7
7
12
12
109 K .
109 K .
113 K .
117 K .
1 day
1 ,,
6 ,,
1 ,,
1 ,,
1 ,,
1 ,.
94
102
103
105
1225/16 . 15 119 K . 105
1227/22 . 15 120 K . 105
1227/23 . 15 120 K . 105
2 .Acute toxaemia.
2 . . ..9
12 .Cannibalised.
2 .Acute toxaemia.
2 . .. . .
2
2
660 . .. .Multiple tumours. Broncho-
pneumonia; papillary adenoma.
670 .....No abnormality found.
670 +....Multiple tumours. Papillary
adenoma.
690 + ...Multiple tumours. Papillary
adenoma with bony meta-
plasia; hepatoma.
690 . ± + + + . Multiple tumours. Multifocal
papillary adenoma, carcinoma,
and alveolar hyperplasia.
690 + .A + . ? Multiple tumours L. Papillary
adenoma and alveolar hyper-
plasia.
690. . . + . ? Tumour R.L. lobe.
The tables show the survival of each mouse, the period of administration,
the total dose ofINH and the neoplastic pulmonary lesions classified by anatomical
site and histological type. Neoplastic lesions found in untreated control animals
killed at comparable ages are also shown (Tables V and VII).
Wistar Rats
Group 1. Subcutaneous injection ofINH
Nine male and 8 female weanling rats about 4 weeks old received 34 subcut-
aneous injections of 0.2% INH solution (10 mg. per 100 g. body weight) during
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TABLE V.-Controls-C3Hf Mice.
Lung
2 3 4 Autopsy and histological diagnosis
.. .. ... Pneumonia
.. .. .. . No gross lesions.
.. .. ... Lung congested and has metastatic tumours from liver
cell carcinoira.
.. .. .. . Enteritis and liver abscesses (Tyzzer's disease).
..~~~~~ . .. .. . . .
.. .. .. . No gross lesions.
.. .. ... Cystic liver tumour. Trabecular hopatoma (cystic) and
liver coll carcinoma.
.. .. .. . No gross lesions.
.. .. .. . Liver tumour L. central lobe. Trabecular hepatoma.
.. .. .. . Lungs congested.
.. .. .. . No gross lesions.
.. .. .. . Liver tumours. Multicentric trabecular hepatoma.
.. .. .. . No gross lesions.
.. .. ... Liver tumours and abscesses (Tyzzer's disease). Trabe-
cular hepatoma.
.. .. .. . Multicentric trabecular hepatoma.
.. .. .. . Hyperplastic mesenteric lymph nodes.
+ One small focus of alveolar hyperplasia R.U. lobe.
.. .. .. . No gross lesions.
..+ .. . Tumour R.U. lobe. Alveolar hyperplasia and papillary
adenoma.
.. .. .. . Lungs congested. Alveolar desquamation.
.. .. .. . Abscess in R. lachrymal gland.
One small subpleural tumour L. lobe. Alveolar hyper-
plasia.
.. .. .. . No gross lesions.
.. .. .. . Multiple liver tumours. Pleomorphic hepatoma and liver
cell carcinoma.
.. .. .. . No gross lesions.
R. ovarian haemorrhagic cyst.
No gross lesions.
R. ovarian cyst.
L. lobe pale. Inflammatory exudate in lung.
. Small lesion apex of R.U. lobe. Alveolar hyperplasia
associated with lymphatic engorgement.
Congested lung.
One tumour R.U. lobe. Subpleural alveolar hyperplasia.
No gross lesions.
L. leg paralysed. Osteogenic sarcoma oflumbar vertebrae.
No gross lesions.
Pyometra.
No gross lesions.
Endometrial hyperplasia.
Uterus enlarged. Recurrent haemorrhages from haeman-
gioma.
Large haemangioma of uterine wall.
Muscular hypertrophy of uterine wall.
Septic bronchitis. Papillary adenoma, endometriosis.
No gross lesions.
Simple ovarian cysts.
Small cyst L. ovary.
No gross lesions.
Small lesions R.U. lobe. Subpleural lymphangitis.
Fibromyoma of uterus.
Small lesion R.L. lobe. Not confirmed histologically.
No gross lesions.
Obstruction to rectum by pressure of uterine adano-
carcinoma; metastases in lung and pancreas.
No gross lesions.
96K.
98K.
98K.
103K.
105 K.
105 K.
105 K.
105 K.
105 K..+
105 K.
105 K.
108
110 K.
110 K.
110 K.
110K.
110K.
110K.
111K .
111 K .
112 K .
112 K .
112 K .
113 K.
114 K .
114 K .
119
128
Age in
weeks ,
at death 1
87.
91 K ..
93 K.
100
101
103 K.
104 K.
104 K.
105 K.
105 K.
105 K.
105 K.
106 K.
108 K.
i09 K...
109K.
109 K.
111K. ..
111K...
112K. K
113 K.
113 K.
116K...
118K...
119K...
119K...
No.
Males
1611/1
1604/1
1604/2
1603/1
1603/2
1593/1
1606/1
1616/1
1596/1
1596/2
1612/1
1612/2
1602/1
1606/2
1603/3
1603/4
1607/1
1604/3
1604/4
1609/1
1600/2
1611/2
1589/1
1614/1
1614/2
1614/3
Females
1608/1
1579/1
1597/2
1594/1
1613/7
1613/8
1613/9
1613/10
1595/1
1595/2
1592/1
1627/1
1605/1
1605/2
1591/1
1615/1
1615/2
1615/3
1590/1
1590/2
1598/1
1598/2
1601/3
1610/3
1599/1
1599/2
1627/3
1627/4
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TABLE VI.-INH in Drinking Water-BALB/c Mice
Age in weeks INH
c-e Dura- Total
at at tion dose
start death (weeks) (mg.)
104 11 . 3 days . 6
10 11 .3 ,, . 6
13 16 . 3 . 12
13 19 . 6 . 24
14 48 . 34 . 126
14 72 . 58 . 409
12 80 K. 72 . 503
14 81 . 67 503
13 90 K. 77 . 540
9 98 K. 89 . 628
9 98 K. 89 . 628
9 98 K. 89 . 628
11 105 K. 94 . 650
13 106 . 93 . 650
14 108 K. 94 . 663
10
10
14
10
10
9
9
9
9
10
11
11
11
11
11
11
11
11
13
14
42
79
80
98 K .
98K .
98K .
98 K .
102
103
105 K .
105 K .
105 K .
105 K .
105 K .
105 K .
105 K
3
4
28
69
70
89
89
89
89
92
92
94
94
94
94
94
94
94
14 108 K. 94
14 108 K . 94
Lung
1 2 3 4
Autopsy and histological
diagnosis
.. .. .. .. . Acute toxaemia.
... .. .. ... Cannibalised.
... .. .. ... Autolytic.
.. .. .. .. . Generalised lymphomatosis.
... .. .. ... Pulmonary congestion and
oedema.
...+ .. ... Pneumonia. Splenomegaly.
.. .. .. .. . Head eaten; lung congested.
.. .. .. .. . Visceral lymphomatosis; lym-
phatic leukaemia.
.+ + .. ... Three separate tumours, R.
lung.
.±+ .. .. ... Tumour, R.M. lobe.
.. + .. .. . Multiple tumours.
.±+ . . + . . . Subpleural tumours.
+ . Multiple tumours. Multicentric
alveolar hyperplasia.
.+ .. ... Multiple lung tumours. Papil-
lary adenomata. Forestomach
-hyperkeratosis.
21 ... Pneumonia.
28 ....Cannibalised.
196 .Two tumours L. lobe. Adeno-
mata.
486 ? Tumour R.L. lobe. Pneu-
monia.
492 Tumour R.M. lobe. Haemor-
rhagic gastroenteritis.
628 . + +.. Multiple tumours in lungs. Bony
metaplasia in adenomata.
628 .....No abnormalities found.
628 . + + + + Multiple tumours. Adenoma
and hyperplasia.
628 + + Multiple tumours. Adenoma
and hyperplasia.
646 + ....Tumours R.U. and R.L.;
splenomegaly. Lymphatic
leukaemia.
648 + Tumours R.U.; haemorrhagic
gastroenteritis.
663 + Large multifocal papillary
adenoma R.U.
663 Tumours R.U. and R.L. Multi-
focal papillary adenoma.
663 . + + . Multiple tumours.
663 . .. Tumours in all lobes.
663 + +
663 + + . Tumours upper left lobe.
663 + Tumour R.M. Papillary aden-
oma; lymphangitis; L.
ovarian cyst.
663... . Tumours R.U. and L. Alveolar
hyperplasia.
662 . + + .. . Tumours R.U., R.M., R.A., and
L. Adenomata.
No.
Males
1250/26
1250/28
1245/7
1245/8
1247/15
1247/17
1271/32
1245/10
1245/9
1271/31
1271/33
1271/34
1250/27
1247/18
1247/16
Females
1248/20
1248/22
1244/5
1249/25
1246/12
1272/35
1272/36
1272/37
1272/38
1240/13
1248/19
1246/11
1246/14
1248/21
1249/23
1249/24
1251/29
1251/30
1244/6
1244/4
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TABLE VII.-Controls-BALB/c Mice.
Age in
weeks ,
at death 1
96 .+
98K. +
99 K.+
99 K.
99K. +
. 101
101 K.
101 K.
o101K.
83 +
101K. ±
101K. +
101 K.
101 K...
101 K.
102 K.
102K. +
102K. +*
102K. +
102K. +
102K. +
102 K.
103.
103 K.
103 K.
103K.
104 K.
104K.
104K. +
104K. +
104K ...
104K.
104 K.+
105K. +
105K. ..
105K. +
Lung
2 3 4 Autopsy and histological diagnosis
.. .. .. . Lung tumours. Papillary adenoma; lymphatic engorge-
ment.
+ .. .. . Lung tumours. Cystic lymphangectasis, skeletal lympho-
matosis.
.+ .. . Lung tumours. Lymphomatous nodules in spleen.
.. .. .. . Subpleural lymphoid hyperplasia.
+ .. ... Lung tumours. Multifocal papillary adenomata; carci-
noma of liver.
+ .. ... Lung tumours. Multifocal papillary adenomata.
.. .. .. . No abnormality found.
+ .. + Lung tumours. Multifocal papillary adenoma and
carcinoma of lung.
+ .. ... Lung tumours. Myeloid leukaemia with liver and spleen
enlarged.
+ .. ... Large tumours in R.U. lobe. Multifocal papillary
adenomata.
.. .. .. . Tumour R.U. lobe; cystic ovary. Papillary adenoma.
+ +I-- . Multiple lung tumours. Alveolar hyperplasia and papil-
lary adenoma.
.. .. .. . No abnormality in lungs; cystic R. uterine horn.
Endometriosis.
.. .. .. . No abnormality in lungs; L.3 mammaryadenocarcinoma;
visceral lymphomatosis.
.. .. .. . Large mediastinal nodes; uterus distended. Pyometra.
.. .. .. . No abnormality in lungs.
+ + . Multiple tumours. Papillary adenoma, carcinoma and
lymphatic leukaemia.
.. .. .. . Tumour R.L. base.
+ . Multiple lung tumours. Papillary adenoma and alveolar
hyperplasia. R.1 and 3 mammary adenocarcinoma;
lymphomatosis.
.. + ... Large tumour R.L. Multifocal papillary adenoma.
+ .. ... R.L. apical lesion. Papillary adenoma. Visceral lymph
nodes enlarged. Inflammatory hyperplasia.
.. .. .. . Generalised lymphomatosis.
.. .. ... Lymphomatosis.
..+ .. . Large nodular spleen; small nodule R. uterine horn;
lymphomatosis. Alveolar hyperplasia.
.. .. ... Tumour in neck and all lymphoid sites. Lymphatic
leukaemia.
Tumour R.M.; haemorrhagic ascites. Malignant
haemangio-endothelioma.
-.+ .. . Small tumour R.U. lobe. Papillary adenoma; alveolar
hyperplasia.
+ .. . Large tumour R.U. lobe. Papillary adenoma; alveolar
hyperplasia.
..+ .. . Tumour R.A. lobe. Papillary adenoma; alveolar
hyperplasia.
+ + . Multiple tumours in lung. Multifocal papillary adenoma
and carcinoma; lymphomatosis.
+ .. ... Large clear cyst R.U. lobe. Multifocal papillary adenoma;
Uterine mucocele.
.. .. .. . No abnormality found.
.. .. .. . Tumours R.U. and L. lobes. Multifocal papillary adenoma.
+ .. ... Tumour R.M. lobe. Papillary adenoma and carcinoma.
R.3 mammary adenocarcinoma.
... . No abnormality found.
+ .. ... Tumour R.L. Multifocal papillary adenoma and carci-
noma.
No.
Males
1584/2
1565/1
1178/1
1178/2
1178/3
1575/1
1575/2
1575/3
1572/1
Females
1583/1
1577/1
1577/2
1577/3
1576/1
1576/2
1571/3
1571/4
1571/5
1573/1
1574/1
1564/2
1564/3
1579/2
1570/3
1570/4
1563/1
1563/3
1566/4
1566/5
1566/6
1569/1
1569/2
1568/1
5/1
1567/1
1581/1
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Age in
weeks
No. at death
TABLE VII. (contd)
Lung
1 2 3 4 Autopsy and histological diagnosis
1580/1 . 106 K . .. .. .. ... . Huge lymphomata invading kidney and retroperitoneal
tissues.
1580/2 106 K . + . . + .. . Tumours R.U. and R.L. lobes. Papillary adenoma and
alveolar hyperplasia.
1580/3 106 K . + + + .. . Large tumours R.U. and R.L. lobes. Papillary adenoma.
1580/4 . 106K ... .. . ? Tumour L. lobe (leukaemic); general lymphomatosis.
Lymphatic leukaemia.
1580/5 . 106 K . .. .. .. .. . No abnormality found.
108
109 K
109 K
1579/2 . 110 . ..
.. . . .. . ,, ,, ,, in lung. Tyzzer's disease of liver.
.. .. .. . General lymphomatosis.
.. .. ... Huge tumour L. lung. Multifocal pleomorphic adeno-
carcinoma.
.. .. .. . General lymphomatosis.
a period of 24 weeks, equivalent to a total dose of 680 mg. All the males were
killed aged 28 to 29 weeks. Two females were found dead aged 21 weeks, and 6
were killed aged 29 weeks.
Group II. Intraperitoneal injection ofINH
One male and 6 females 24 weeks old received 20 intraperitoneal injections of
0.2% INH solution over a period of 16 weeks, giving a maximum total dose of
550 mg. Two females were found dead aged 85 and 106 weeks, respectively, and
the 1 male and 4 females were killed aged 77, 85, 95 (2) and 106 weeks.
Results.-No tumours were found in the lungs or in any other organ or tissue
in the animals in Group I and II.
Group III
A small group of 4 male and 4 female rats aged 8-10 weeks were given 0.25%
INH solution daily in drinking bottles throughout the experiment. A 200 g.
rat consumed an average daily dose of 18 mg. INH (Table VIII).
TABLE VIII.-INH in Drinking Water-Wistar Rats.
Age in weeks
at at
No. start death
Dura-
tion
(weeks)
6 17 K . 11
6 30K . 24
INH
Total
dose
(gm.)
1-8
2-7
7 40K . 33 . 4-0
6 48K . 42 . 5-0
Lung
1 2 3 4
Autopsy and histological
diagnosis
.. .. .. ... Bronchiectasis with squamous
metaplasia.
.. .. .. ... Pulmonary interstitial hymph-
angitis.
.. .. .. .. . Paraplegic; cause not found.
.. .. .. ... Congestion and bronchitis with
local necrosis.
7 40 33 4 0 .. . .. .. .
6 54 K. 48 . 5-8. . .. .. ..
7 87 K. 80 11.0 .. . .. .. .
7 113 K. 106 . 13-0 . + .. + + .
Congestion and local necroses in
bronchi.
Bronchopneumonia.
Pneumonia and bronchiectasis.
Foreign bodies in peripheral
alveolus; local lymphangitis,
Alveolar hyperplasia and papil-
lary adenoma (F:g. 3 and 4).
1579/3
1579/1
1579/4
Males
60/42
58/38
58/37
60/41
Females
57/36
59/39
59/40
57/35
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Results. There was a high incidence of respiratory lesions; bronchitis,
bronchiectasis and broncho-pneumonia were present at death in all but the young-
est, but only the last surviving female aged 113 weeks showed central and sub-
pleural alveolar hyperplasia and papillary adenoma (Fig. 3 and 4) comparable
with the lesions so described in mice (Peacock and Peacock, 1966).
Group IV
A group of 14 males and 9 females were given INH in drinking water and
food for 20 weeks by which time they showed loss of appetite and consequent
loss of weight because they drank less than controls. Those that died were
found to be constipated, some with the whole length of the colon distended with
faeces. The INH solution was therefore withheld for a week and replaced by
tap water which the rats drank avidly. Thereafter the INH solution was given
on alternate weeks only, for a further 35 weeks by which time the animals had
regained and maintained normal weight. However, they did not drink as much
as controls and the drug was therefore mixed with the food in quantity to give the
same average daily dose supplemented by tap water ad libitum.
The animals tolerated this regime well and the survivors were killed when
approximately 2 years old.
Results. The course of the experiment is shown in Table IX. Only one
hyperplastic and neoplastic subpleural pulmonary lesion was found. Many
animals had chronic respiratory infections but there was an unexpected incidence
of 5 cases ofrectal prolapse, 4 ofwhich were associated with squamous metaplasia
of the glands of the terminal part of the rectum and with multifocal squamous
papilloma of the anal margin (Fig. 6, 7, 8), one showing areas of possibly early
squamous carcinoma (Fig. 5).
Further reference to these cases will be made under Discussion.
No comparable lesions were seen in 15 male and 14 female Wistar rats kept
during the experimental period as controls. (Table X).
Desert Rats (Meriones lybicus)
JNH in drinking water
Seventeen males and 11 females aged 4 months were given INH daily in
drinking water as a 0 25% solution throughout their lives.
Results.-The results are shown in Table XI.
No lung tumours were found but in the two oldest males, killed at 128 weeks
of age, there were small foci of subpleural lymphatic engorgement of the type
associated in mice and rats with alveolar hyperplasia. No tumour at any site
in either sex was found in 5 male and 6 female desert rats of comparable ages
(all over 1 year).
Hamsters (Mesocricetus auratus)
Intraperitoneal injection of INH
Three males and 2 females aged 8 weeks received 15 intraperitoneal injections
of 0.10% INH in water, equivalent to 10 mg. INH per 100 g. body weight and a
total dose of 90 mg.
Results.-One male died aged 51 weeks and 2 were killed at 66 and 67 weeks,
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TABLE IX.-INH in Drinking Water and Food-Wistar Rats.
INH
Dura- Total
tion dose
(weeks) (gum.)
10 . 1-8
11 . 1-9
13 . 1-61
13 . 1-61
13 . 2-07
23 . 3- 63
49 . 6 39
51 . 6-51
66 . 6-54
67 . 6-56
69 . 6-70
71 . 6-72
72 . 6- 72
72 . 6- 72
12 . 1-63
53 . 6-23
53 . 6- 23
66 . 6- 54
67 . 6-54
70 . 6- 72
7 109 K . 71 . 9-3
8 109 K.
8 109 K .
70
70
9 3
9 3
respectively. The females died at 61
of the lung or other organ were foun
Lung
1 2 3 4
Autopsy and histological
diagnosis
... .. .. ... Bronchiectasis and squamous
metaplasia.
.. .. .. .. . No abnormality found.
.. .. .. .. . No abnormality found.
.. .. .. .. . No abnormality found.
... .. .. ... Subpleural lymphangitis and
congestion.
... .. .. ... Bronchopneumonia. Bronchial
adenosis. Anal papilloma, and
early carcinoma (Fig. 5).
.. .. .. .. . Left lung collapsed.
.+ .. ± .. . Bronchiectasis and partial col-
lapse. Alveolar hyperplasia.
... .. .. ... Lungs normal. Pleomorphic
sarcoma R. hip and flank.
.. .. .. .. . Lungs congested.
... .. .. ... Bronchiectasis and bronchial
adenosis.
... .. .. ... Bronchiectasis and bronchial
adenosis.
.. .. .. .. . Pigmented macrophages in lym-
phatics.
. .. .. .. .. . Bronchiectasis; abscess in
pyloric wall.
... .. .. ... No abnormality found. Per-
sistent rectal prolapse.
... .. .. ... Prolapsed rectum. Keratinised
papilloma ofanalskin. (Fig. 6).
. .. .. .. .. . Bronchopneumonia; prolapse.
Keratinising papilloma and
squamous metaplasia and car-
cinoma ofanal glands. (Fig. 7).
. .. .. .. .. . Malignant hepatoma; meta-
stases in lung.
... .. .. ... Pyometra and subphrenic
abscess.
.. .. .. .. . Lungcongested. Nodular hyper-
plasia of liver. Papillomatous
anal polyp. (Fig. 8).
... .. .. ... Tumour L. side of thyroid.
Cystic ovaries. Thyroid carci-
noma.
... .. .. ... Bronchiectasis. Hepatoma,
cystic ovaries.
... .. .. ... Bronchiectasis and bronchial
adenosis.
9 and 89 weeks, respectively. No tumours
id.
INH in drinking water
Seven males and 9 females were given 0.25% INH solution in drinking water
daily throughout their lives.
Results.-No pulmonary tumours were seen. The course of the experiment
and total dosage are shown in Table XII.
Age in weeks
at at
start death No.
Males
60/42
78/13
81/18
81/19
78/12
75/4
64/1
75/5
79/15
79/14
80/17
74/2
74/3
80/16
Females
77/9
76/7
76/8
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
17 K .
18 K .
19K .
19K .
21 K.
61 K .
88K.
96K .
97
98
105 K .
109 K .
109 K .
109 K .
19 K .
78 K .
78K .
97
100 K .
108 K .
8
8
7
77/11
77/10
76/6
82/20
82/21
82/22
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TABLE X.-Controls-Wistar Rets
Age in Lung
weeks A
No. at death 1 2 3 4 Autopsy and histological diagnosis
Males
62/5 . 75 .Peribronchial lymphatic engorgement.
65/13 . 90 K .Emphysema and lymphangitis.
61/1 . 91 K .Bronchopneumonia.
69/20 . 100 .Desquamative pneumonitis.
73/1 . 102 K .Enteritis.
71/27 . 104 K .No abnormality found.
62/4 . 106 K .Early bronchiectasis; abscess in mastoid sinus.
61/3 . 107 K .Peribronchial lymphangitis. Fatty liver.
61/2 . 108 .Bronchiectasis, chronic peritonitis. ? Healed intestinal
perforation.
66/14 . 108 K .Bronchiectasis.
72/28 . 110 K .Haemorrhagic infarct of spleen.
71/24 . 110 K .No abnormality found.
65/11 . 110 K .No abnormality found.
65/12 . 110 K .No abnormality found.
71/25 . 112 K .Fatty liver.
Females
64/9 . 82 K .No abnormality found.
63/7 . 98 K .Fibroadenoma of breast; adenocarcinoma of ovary.
64/10 . 98 K .Bronchopneumonia.
66/15 . 102 K .No abnormality found.
68/18 . 105 .Scirrhous adenocarcinoma of breast; metastases in lung.
67/17 106 K .Adenosis of breast.
70/23 . 106 K .Congested lung. Interstitial nephritis.
68/19 . 107 K .Congested lung.
72/29 . 109 K .Myoma of uterus.
67/16 . 109 K .Cystic endometriosis.
70/21 . 111 K .Chronic interstitial nephritis.
70/22 . 111 K .Columnar cell adenocarcinoma of uterus.
63/8 . 113 K .Cystic adenocarcinoma of ovary, invading small intestine.
63/6 . 114 K .Septic bronchitis. Anaplastic ovarian carcinoma invading
kidney and muscle; necrotic metastases in lung.
DISCUSSION
Only in C3Hf mice was the incidence of lung tumours clearly increased by
treatment with INH (Tables IV and V).
In our short term groups of BALB/c mice given INH by gastric intubation
the results were confused by the high incidence of unresolved septic bronchitis,
bronchopneumonia and bronchiectasis associated in 2 animals with papillary
adenoma.
In long term experiments there was no significant difference between the
experimental and control BALB/c mice at about 2 years of age. C3Hf mice, on
the other hand, with a lower spontaneous incidence of pulmonary tumours,
showed a significantly increased incidence of tumours attributable to INH.
We have adopted a method of classification of lung tumours in mice based on
the anatomical site of origin and histological criteria of neoplasia (Peacock and
Peacock, 1966) and this method has been used also in examining the lungs of the
other species of rodent.
Positive records under each heading were all confirmed, unless otherwise
stated, by examination of serial sections through the macroscopically visible
lesions. Often smaller lesions involving even a few cells were discovered during
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such examinations. No attempt has been made to enumerate the lesions of each
type in this study because many lesions are obviously multicentric in origin and
some are so small or so early that they might be debatable.
Despite these limitations it is obvious that INH is carcinogenic for C3Hf
mice, but not obvious in the case of BALB/c mice, in our experiments.
Bianciflori and Ribacchi (1962) showed that daily administration of 2 mg.
of INH by gastric intubation caused pulmonary tumours in all of 38 virgin
female BALB/c mice which survived for 46 weeks following the start oftreatment
at 8 weeks of age. Their total dosage was 502 mg. They saw no pulmonary
tumours in untreated controls.
In our experiments approximately the same total dosage was given over
80-120 weeks, with similar results in BALB/c mice of both sexes, but at that age
the untreated controls also had a high incidence of spontaneous tumours.
The tables show the sex, age and duration of exposure to INH, the total dose
per animal and the incidence and site of origin of hyperplastic and neoplastic
TABLE XI.-INH in Drinking Water-Meriones lybicus
Age in weeks INH
A Dura- Total
at at tion dose
No. start death (weeks) (g.) Autopsy and histological diagnosis
Males
18/26 . 5 39 . 34 . 3 52 . Lungs congested. Liver congested with pale spots
(fatty change).
18/25 . 5 39 . 34 . 3-52 . Vesical calculus obstructing urethra. Small cortical
adenoma of adrenal
9/7 . 18 56 K . 38 . 4 04 . Killed for foot injury. Subpleural lymphatic
engorgement.
9/8 . 18 56 K . 38 . 4 04 . Killed for foot injury. Vesical calculus, but not
causing obstruction
11/13 . 19 88 . 69 . 7-22 . Autolytic. No gross lesions.
9/9 . 18 96 . 78 . 8-25 . .. ..
8/5 .18 106 . 88 .9 27. .. ..
16/23 . 18 109 . 88 . 9 27 . Pneumonia.
8/4 . 18 109 . 91 . 9.57 . Ureteric calculi; cystitis.
8/6 . 18 111 K . 93 9-81 . Spastic muscular paralysis. C.N.S. appears normal.
11/14 . 19 117 K . 98 . 11-28 . Killed in good condition. No gross lesions found.
10/12 . 19 126 . 108 . 11-37 . Lungs congested and slightly oedematous.
17/24 18 127 . 109 . 11-52 . No gross lesions.
10/10 . 19 127 . 108 . 11-38 . Small cysts in liver. Cholangiectasis and fatty
change.
10/11 . 19 127 . 108 . 11-52 . No gross or histological abnormalities.
12/15 . 19 128 K . 109 . 11-43 . Killed in good condition. Slight focal alveolar
hyperplasia and prominent subpleural lymphatics.
12/16 . 19 128 K . 109 . 11-43 . Killed in good condition. Slight focal alveolar
hyperplasia and prominent subpleural lymphatics.
Females
14/19 . 19 60 . 41 . 4- 32 . Autolytic. No gross lesions.
14/20 . 19 76 . 57 . 5-98 . Accidental hyperthermia. Lungs congested.
19/27 . 5 101 . 96 . 10-08 . Teeth caught in cage bars. Autolytic.
19/28 . 5 114 K . 109 . 11-43 . Hepatoma with advanced fatty change.
7/1 . 18 120 K . 102 . 10- 75 . No gross or histological abnormality.
7/2 . 18 120 K. 102 . 10-75 ., ..
7/3 . 18 120 K. 102 . 10- 75 . ..
15/21 . 19 127 K. 108 . 11-38 . ..
15/22 . 19 127 K. 108 . 11-38 . ..
13/17 . 19 128 . 109 . 11-43 . ..
13/18 . 19 128 . 109 . 11-43 . Liver shows fatty change.TOXICITY OF ISONIAZID
lesions. Where nothing is shown under headings Lung 1 to 4 in the tables, no
hyperplastic or neoplastic lesions were present, though in many of the animals
there were inflammatory lesions ofthe lungs. In all cases the lungs were inspected
and with a few exceptions routine random histological sections were examined,
even in those that appeared normal.
In Wistar rats the only pulmonary lesions which might be attributable to
INH were 2 cases of subpleural alveolar hyperplasia and one of early papillary
adenoma (Fig. 3 and 4).
The occurrence of one case of persistent rectal prolapse and 4 cases of prolapse
associated with squamous metaplasia of the columnar epithelium of the anal
canal and varying degrees of further neoplastic progression was remarkable in a
group of 22 rats.
On tracing the pedigree of the affected rats it was found that the 4 females
were litter mate sisters of a family of 6 sisters and 4 brothers.
The first to develop prolapse of the rectum was killed aged 19 weeks and was
found to be constipated but showed no macroscopic lesion of the rectum or anal
canal and only the lungs were examined histologically and found to be normal.
Of the other 2 sisters one died aged 97 weeks and was found to have multifocal
haemorrhagic hepatomata in the lower right lobe and central lobes of the liver
with metastases in the lung. All showed the structure ofhepatocellular carcinoma.
The remaining sister was killed aged 100 weeks. The right horn of the uterus
was the seat of pyometra and there were enlarged para-aortic lymph nodes and
there was a large hard mass in the upper abdomen adherent to the liver and to
the abdominal wall which proved to be an abscess. The other 3 sisters with
TABLE XII. INH in Drinking Water Hams3ter8.
Age in weeks
at at
No. start death
Dura-
tion
(weeks)
INH
Total
dose
(g-)
8 31 23 1 98
8 77 K. 69 6-0
48 81 K. 33 . 2-91
21 82 K. 61 . 5-36
21 82 K. 61 5-36
7 97 . 90 . 7- 88
7 97 . 90 . 7- 88
9 26 . 17 . 1- 47
7 40 33 2 - 90
30 45 K. 15 1-33
19 48 29 . 2 - 58
38 54 K. 16 1-41
10 59 49 . 4- 33
8 77 K. 69 6-0
7 78 K. 71 6-23
56 89 K. 33 . 2-91
Autopsy and histological diagnosis
No gross lesions.
Killed in poor condition. No gross lesions.
Killed in poor condition. Nephritis; casts in
tubules.
Killed in poor condition. Chronic nephritis;
hyaline casts in tubules.
Killed in good condition. No lesions found.
Lobar pneumonia. Cholangiectasis.
Lungs congested.
Partly cannibalised. Lungs pneumonic.
Caught in cage. Stomach and intestine empty. No
lesions found.
Killed in poor condition. Lungs congested.
Lungs congested.
Killed in poor condition. No gross lesions found.
Partly cannibalised. Lungs congested.
Killed in poor condition. Hepatoma; squamous
papilloma, in forestomach.
Killed in poor condition. Liver focal haexnan-
gioma.
Prolapsed rectum; no lesions found.
Males
25/13
22/7
19/25
26/17
26/18
25/14
25/25
Females
24/12
19/28
20/1
21/6
20/2
23/9
23/10
24/14
24/11
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prolapse and anial tumours were caged together throughout their lives. Two
were killed aged 78 weeks forprolapse and perineal tumours, one had a keratinised
multifocal papilloma apparently originating in the anal skin (Fig. 6); the other
had alarger keratinising squamous papilloma and early carcinoma (not illustrated)
associated with squamous metaplasia of the columnar cell glands of the prolapsed
rectum and anal canal (Fig. 7). The third sister was killed aged 108 weeks in
good condition and was found to have a small wart in the anal canal; histologi-
cally this was a keratinising squamous papilloma. There was a diaphragmatic
hernia ofpart of the central lobe of the liver which showed no histological abnor-
mality; otherwise no abnormality was found. No constipation was present in
these 3 sisters at the time of death. The one male which was killed aged 61
weeks for prolapse had a squamous papilloma and early carcinoma of the anal
canal (Fig. 5) and also had unresolved bronchopneumonia and adenosis of the
bronchial epithelium and an abscess in the right maxilla.
Its cage mate, killed at 96 weeks, also had bronchiectasis and a small patch
of alveolar hyperplasia.
The male with anal papilloma was half-brother to the 4 sisters with similar
lesions, their mothers were litter mate sisters both mated to the same litter mate
brother. However, the grandparents were of heterozygous Wistar stock.
The complexity of the aetiological factors in these rats is apparent. All
were exposed to daily dosage ofINH, all were infested with Demodexfolliculorumn,
and they were closely related. Constipation, a factor predisposing to prolapse,
was common to most of the rats on INH when it was given in drinking water but
not in the latter part ofthe experimental period when it was mixed with the food,
and it is interesting to note the absence of macroscopic tumours in the first of the
sisters killed for prolapse at 14 weeks of age. Unfortunately no sections were
taken in this case. The presence of Demodex infestation of the perineal pilo-
sebaceous glands in these 5 rats is recorded without prejudice. Unfortunately the
observation was made after the death of all the experimental and control animals
during histological study and consequently no contemporary control observations
are available. However, one untreated female survivor from the same stock of
Wistar rats was killed in good condition at 75 weeks of age and immediately
examined. No lesions were found in any organ. Serial sections of skin from
perineal and other sites showed general infestation of pilosebaceous follicles by
Demodex folliculorum, but no inflammatory or other tissue reaction. It seems
probable, therefore, that the whole stock of Wistar rats was infested though they
showed no signs of dermatitis. Desert rats and hamsters showed no lesions
attributable to INH. The ears of the desert rats are frequently infested by
Demodexfolliculorun where it does not seem to cause irritation or gross or micro-
scopic lesions, but some years ago we observed one case of spontaneous squamous
carcinoma of the external auditory meatus associated with Demodex infestation
in this species. We have never found Demodex infestation in hamsters or mice.
Symptomless infestation by Demodexfolliculorum of the pilosebaceous follicles
of facial and mammary regions occurs with undetermined frequency in man
and is usually demonstrable in our experience in the neighbourhood of rodent
ulcers.
Though there is insufficient evidence to justify any opinion on a possible
aetiological role of the Demodex in skin cancer, it seems desirable to record its
presence when observed.
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CONCLUSIONS
While our primary concern was to assess the effect of INH on the lungs of
rodents, the possibility of induced lesions in other tissues had to be borne in mind.
Our results emphasise the peculiar susceptibility of mice to alveolar hyper-
plasia and papillary adenoma of the lung. The results in Wistar rats are not
easy to interpret and call for further investigation, but as regards lesions in the
lungs, the evidence for carcinogenicity of INH is slight. It is suggested that
INH may have promoted progression from squamous metaplasia to neoplasia
in the epithelium of the lower rectum rendered metaplastic by prolapse caused
in turn by constipation. INH may also have acted directly on the squamous
epithelium of the anal margin to induce keratinising papilloma and carcinoma.
The absence of demonstrable neoplastic response in two of the four species of
rodent tested under conditions thought to be realistic in terms of human dosage
with the same drug encourages us to suggest that INH at the dosage level used
in human cases of tuberculosis represents an acceptable carcinogenic hazard.
It is another matter to advocate its use as a prophylactic in healthy babies.
While there seems to be no way of predicting whether or not INH should be
regarded as more or less potentially carcinogenic for man than for rodents, it
would be prudent to assume that there is some degree of risk and to use it only
as a curative drug and limit as far as possible the duration of its exhibition in
each case.
SUMMARY
Isoniazid given in drinking water proved toxic for mice, Wistar rats, desert
rats and hamsters at daily dosage of more than 10 mg. per 100 g. body weight.
The highest tolerable daily dosage levels were established for each strain or species
of rodent, and were reduced temporarily if toxic effects developed.
The methods of gastric intubation, subcutaneous or intraperitoneal injection
for administering INH were abandoned in favour oforal administration in drinking
water or food.
Hyperplastic and neoplastic lesions originating in the pulmonary alveoli
were induced by INH given in drinking water at between 2 and 3 mg. daily in
C3Hf mice killed after approximately 2 years' treatment. Similar dosage in
BALB/c mice gave equivocal results because of the high spontaneous incidence
of similar lesions in untreated controls at 2 years of age.
Wistar rats given INH daily in drinking water lost appetite and weight and
were constipated. Five out of 22 developed rectal prolapse and 4 of these had
squamous metaplasia and papilloma and two early squamous carcinoma of the
anal margin. Of these 5 rats 4 were litter mate sisters and the fifth was a half
brother. The possible aetiological factors are discussed.
Wistar rats showed very little evidence of pulmonary response to INH-2
cases of local subpleural alveolar hyperplasia and early adenoma out of 22 at risk.
Desert rats and hamsters showed no neoplastic response to INH at similar
dosage levels for 2 years.
It is concluded that INH is an acceptable risk when used as a curative drug
for tuberculosis in man, but that it should not be used prophylactically in healthy
babies.
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